Pharmaceutical company responses to Canadian opioid advertising restrictions: A framing analysis

The pharmaceutical industry’s promotion of opioids in North America has been well-documented. Yet despite the clear consequences of improperly classifying pharmaceutical company messaging and frequently permissive approaches that allow the pharmaceutical industry to self-regulate its own advertising...

Descripción completa

Detalles Bibliográficos
Autores principales: Eisenkraft Klein, Daniel, Lexchin, Joel, Sud, Abhimanyu, Bavli, Itai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10310031/
https://www.ncbi.nlm.nih.gov/pubmed/37384735
http://dx.doi.org/10.1371/journal.pone.0287861

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10310031/
https://www.ncbi.nlm.nih.gov/pubmed/37384735
http://dx.doi.org/10.1371/journal.pone.0287861

Ejemplares similares